This post has been de-listed
It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.
A promising MS treatment under development called ATA188 has improved or stabilised 20 of 24 MS patients treated with it in a phase 1 trial. MS is normally a progressive disease.
The treatment takes T cells from healthy donors and uses them to destroy EBV-infected cells believed to cause MS.
This could help those of us whose ME/CFS was EBV triggered.
The treatment is registering MS patients for a phase 2 trial. Unfortunately this trial will run till at least 2026 and be followed by a (fast tracked) phase 3 trial.
For more: IFL Science article: https://www.iflscience.com/health-and-medicine/ms-symptoms-may-have-been-reversed-in-immunotherapy-breakthrough/amp.html
Presentation from the company: https://d1io3yog0oux5.cloudfront.net/_d9ae571e8ab35abbf8204ce868450283/atarabio/db/640/5528/pdf/Atara EBV and MS Day Investor Presentation March 22, 2022_vFinal3.pdf
Phase 2 Clinical trial: https://clinicaltrials.gov/ct2/show/NCT03283826
Subreddit
Post Details
- Posted
- 2 years ago
- Reddit URL
- View post on reddit.com
- External URL
- reddit.com/r/cfs/comment...